MOLN Stock Summary and Trading Ideas (Molecular Partners Ag - American Depositary Shares | NASDAQ:MOLN)

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Molecular Partners Ag - American Depositary Shares trades on the NASDAQ stock market under the symbol MOLN.

As of April 20, 2026, MOLN stock price climbed to $4.41 with 6,266 million shares trading.

MOLN has a market cap of $164.93 million. This is considered a Micro Cap stock.

In the last 3 years, MOLN traded as high as $12.70 and as low as $3.32.

MOLN has underperformed the market in the last year with a return of +11.1%, while SPY returned +36.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MOLN shares. However, MOLN has outperformed the market in the last 3 month and 2 week periods, returning +5.0% and +14.5%, while SPY returned +2.7% and +8.1%, respectively. This indicates MOLN has been having a stronger performance recently.

MOLN support price is $3.95 and resistance is $4.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MOLN shares will trade within this expected range on the day.